ATAI
Ataibeckley Inc
NASDAQ · Pharmaceuticals
$3.77
+0.36 (+10.56%)
Open$3.44
Previous Close$3.41
Day High$3.80
Day Low$3.44
52W High$6.75
52W Low$1.15
Volume—
Avg Volume3.75M
Market Cap1.37B
P/E Ratio—
EPS$-0.57
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+972.7% upside
Current
$3.77
$3.77
Target
$40.44
$40.44
$27.58
$40.44 avg
$50.46
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 690.1K | 2.79M | 413.99M |
| Net Income | -338,516,021 | -1,232,461,241 | 66.80M |
| Profit Margin | -48,464.0% | -46,040.8% | 16.1% |
| EBITDA | -327,292,689 | -1,257,799,573 | 114.08M |
| Free Cash Flow | — | — | 60.27M |
| Rev Growth | -75.3% | -75.3% | +2.9% |
| Debt/Equity | 0.20 | 0.20 | 0.21 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |